(Q54652595)

2 June 2018

title

The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. (English)

1 reference

2 June 2018

main subject

neoplastic invasiveness

1 reference

Jing Zhang

1

1 reference

2 June 2018

Susobhan Sarkar

series ordinal

2

1 reference

2 June 2018

V Wee Yong

series ordinal

3

1 reference

2 June 2018

language of work or name

English

0 references

publication date

20 July 2005

1 reference

2 June 2018

published in

Carcinogenesis

1 reference

2 June 2018

volume

26

1 reference

2 June 2018

issue

12

1 reference

2 June 2018

page(s)

2069-2077

1 reference

2 June 2018

How matrix metalloproteinases regulate cell behavior

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Molecular mechanisms of glioma invasiveness: the role of proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Nf-kappa B, chemokine gene transcription and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Molecular determinants of glioma cell migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Proteases in brain tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Tracking cell invasion of human glioma cells and suppression by anti-matrix metalloproteinase agent in rodent brain-slice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Advances in Molecular Therapies in Patients with Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

CXC chemokine receptor 4 expression and function in human astroglioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGI183

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGI183

1 reference

2 June 2018

PubMed ID

16033774

1 reference

2 June 2018